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OBJECTIVES This study examined the usefulness of thoracic ultrasonography for evaluation of fluid
accumulation in patients with decompensated chronic heart failure (CHF) in comparison
with physical signs, upright posteroanterior chest X-ray and echocardiography.
BACKGROUND Decompensated CHF is frequently accompanied by pleural effusion, suggesting that pleural
effusion is a useful marker for confirming the diagnosis of the uncontrolled stage of CHF.
Thoracic ultrasonography seems to be adequate for this purpose.
METHODS Patients with uncontrolled CHF and an interpretable physical examination, chest X-ray,
ultrasonogram for the heart and thorax and thoracic X-ray computed tomographic (CT) scan
were enrolled in the study (n 5 60). Patients free from thoracic and cardiovascular diseases
served as a control (n 5 22). Thoracic CT scan was used as the gold standard for the presence
or absence of pleural effusion. Variables used to predict body fluid accumulation included the
following: pulmonary rales, jugular venous distension or peripheral edema, roentgenographic
evidence of pulmonary edema or pleural fluid, pericardial or pleural effusion on ultrasono-
graphic study.
RESULTS The reported incidence of pleural effusion detected by thoracic ultrasonography was high
(91%). The incidence of physical signs and roentgenographic signs of body fluid accumula-
tion, however, was modest (56%) to low (33%). The best clinical variable for identifying
patients with decompensated CHF was the detection of pleural fluid by thoracic ultrasonog-
raphy (91% predictive accuracy). This variable also had high interobserver agreement (95%
overall agreement, kappa 5 0.70). There was only 41% to 65% predictive accuracy of other
clinical variables, with 72% to 95% agreement (kappa 5 0.400–0.848).
CONCLUSIONS Thoracic ultrasonography is a simple, sensitive and accurate method for the evaluation of
body fluid accumulation in patients with decompensated CHF. This technique can be used
to assist in making the diagnosis of decompensated CHF if other causes of pleural effusion
have been clinically ruled out. (J Am Coll Cardiol 2000;35:1638–46) © 2000 by the
American College of Cardiology
Although there are several reports (1,2) that cardiac dys-
function can occur without florid signs of cardiac decom-
pensation, congestion is generally considered to be a pre-
requisite for the diagnosis of decompensated chronic heart
failure (CHF) (3,4). Optimal clinical management of CHF
requires monitoring of the symptoms and signs of conges-
tion in order to prevent exacerbation due to fluid accumu-
lation (5). Our recent experience using X-ray thoracic
computed tomography (CT) for the evaluation of heart
failure patients has shown that many decompensated CHF
patients presented with pleural effusions, suggesting that
pleural effusion is a useful marker for confirming exacerba-
tion in patients with established CHF.
Thoracic CT in the supine position is the method of
choice for accurate diagnosis of the presence or absence of
pleural effusion. As a rule, however, CT study cannot be
emergently performed in orthopneic patients with uncon-
trolled CHF. In emergency situations in which CT study is
not available or is not available quickly enough, ultrasonog-
raphy might make a crucial contribution to the diagnosis of
pleural effusion. Some previous studies (6,7) used thoracic
ultrasonography for detection of pleural effusion in heart
failure patients, but these reports did not define the accuracy
of thoracic ultrasonography for evaluation of such patients.
Furthermore, there is no comparative study on the evalua-
tion of body fluid accumulation in uncontrolled CHF
patients among thoracic ultrasonography and traditional
clinical tests. Thus, this study was performed to ascertain
the accuracy and usefulness of thoracic ultrasonography for
evaluation of fluid accumulation in patients with decom-
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pensated CHF in comparison with physical signs, upright
posteroanterior chest X-ray and echocardiography.
METHODS
Study population. Between April 1997 and January 1999,
94 patients were consecutively admitted to our institution
with a diagnosis of exacerbation of stable CHF or acute
heart failure (8) requiring diuresis to improve their symp-
toms and signs of congestion and were initially considered
for recruitment to this study. The patients had dyspnea
upon mild to moderate exertion or at rest (New York Heart
Association [NYHA] class II to IV) with objective evidence
supporting the diagnosis of decompensated CHF: docu-
mented heart disease, cardiogenic pulmonary or peripheral
edema of cardiac origin. Patients with acute coronary
syndrome (n 5 9), pericardial disease (n 5 3) or acute
valvular regurgitation were not included in this study.
Patients with complicating inflammatory pulmonary or
pleural disease (n 5 6), renal failure (n 5 4), hepatic
cirrhosis (n 5 2) or pleural exudates of unknown cause (n 5
3) were also excluded from the study. Of the 67 remaining
patients fulfilling the selection criteria, plain chest radio-
graphs or ultrasonographic images were of low quality in
four patients, and thoracic CT study could not be performed
in three other patients. Thus, 60 patients with exacerbation
of established CHF and an interpretable physical examina-
tion, upright posteroanterior chest X-ray, ultrasonogram for
the heart and thorax and thoracic CT results were enrolled.
In addition to the study group, a total of 22 patients (13
men and 9 women; mean age of 67.8 6 22.3 years) with
suspected pulmonary or thoracic aortic diseases, no cardio-
vascular disease and who underwent thoracic CT study and
were ultimately proven to be free from significant CT
findings served as a control to evaluate the diagnostic
accuracy of the traditional clinical tests and thoracic ultra-
sonography for detection of body fluid accumulation. None
of the study patients had any discernible renal impairment,
with the serum creatinine values of all subjects being below
2 mg/dl. Plasma thyroidal hormone was measured in pa-
tients with pericardial effusion or atrial fibrillation to con-
firm a euthyroidal state.
Methodology. Detailed data were collected prospectively
at the time of the diagnosis in study patients meeting criteria
for heart failure. Each patient provided written informed
consent before participating in the study. Data obtained
immediately after admission included a thorough cardiovas-
cular history and physical findings, blood chemistry, elec-
trocardiogram (ECG), upright posteroanterior chest X-ray
and ultrasonographic examination for the heart and thorax.
To confirm myocardial failure, a serum assay for atrial
(normal range: #43 pg/ml) and brain natriuretic peptide
(#18.4 pg/ml) was performed (9,10). After completion of
admission data collection, all subjects underwent chest
X-ray CT study as early as possible (41 [68%] within 2 h, 12
[20%] within 12 h and 7 [12%] within 24 h after admis-
sion). Diagnostic thoracentesis and pericardiocentesis were
performed appropriately to confirm the cause of effusion
(11). Patients were initially treated with some combination
of oxygen, digoxin, nitrate, diuretics, sympathomimetic
agents and synthetic human alpha atrial natriuretic peptide.
Clinical, serum natriuretic peptides, ECG, plain chest X-ray
and ultrasonographic examinations were repeated during a
follow-up period.
Bedside physical examinations. Pulmonary crackles or
rales were recorded as present or absent. Jugular venous
distension was deemed present if venous pulsations were
visible at 45° from the horizontal plane (12). The presence
or absence of peripheral edema and of a third heart sound
was also noted.
Chest radiography. All radiographs were evaluated for the
presence or absence of cardiomegaly (cardiothoracic ratio
more than 0.5), venous redistribution (upper lobe vessels
more prominent than lower), interstitial edema (hilar haz-
iness, peribronchial cuffing, Kerley B lines) or alveolar
pulmonary edema and pleural effusion (13–15).
Cardiac ultrasonography. Echocardiography was per-
formed using a commercially available real-time wide-angle
phased-array system incorporated with a color-Doppler
system (Aloka SSD-2000, Aloka Co. Ltd., Tokyo, Japan).
Standard imaging views were obtained with the patient
lying in the left lateral decubitus position. Full
two-dimensional, M mode, color flow and Doppler studies
were performed on each patient. Pericardial effusion was
defined to be present when an echo-free space was clearly
visualized between the epicardium and pericardium and was
associated with flattening of the pericardial echo relative to
the epicardial echo (16). An anterior echo-free space in the
absence of a significant posterior echo-free space was not
considered indicative of pericardial effusion (16).
Thoracic ultrasonography. After completion of the echo-
cardiography, the patient was asked to assume a sitting
position. The thoracic ultrasonographic study (6,7,17–21)
consisted of echographic investigation of each hemithorax
using a 3.5 MHz sector transducer through the intercostal
space avoiding the ribs. The liver and spleen, and occasion-
ally the kidney, were used as guides to thoracic ultrasonog-
raphy for the detection of pleural fluid. The ribs and the
interface of lung and pleura are readily identified, with the
latter reflecting most of the acoustic energy and appearing as
a bright white line often associated with distal reverberation
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echoes. Identification of a smaller amount of the pleural
fluid in heart failure patients is ordinarily accomplished by
applying the transducer on the posterolateral thoracic wall
where the most dependent portion of the costophrenic
sulcus in the pleural space can be detected in the upright
position. As the pleural effusion accumulates, it gradually
extends from this portion to the lateral and eventually
reaches the anterior costophrenic sulcus. Shallow respiration
enhances the ability of ultrasonography to detect fluid
collection, which appears as an echo free space between the
lung and the adjacent abdominal organ (i.e., the liver in the
right hemithorax and the spleen in the left hemithorax).
Figure 1 shows a representative example of thoracic ultra-
sonographic findings in a CHF patient with bilateral pleural
effusion.
X-ray thoracic CT. For the evaluation of pleural effusion,
a whole body CT scanner (Toshiba Medical Co., Tokyo,
Japan; CT scanner X speed), which utilized a continuously
rotating gantry and pulsed anode with X-radiation colli-
mated to form a thin fan-shaped beam, was used. At least
two separate windows of varying contrast were viewed at
each level, including the areas of water density, for the
analysis of pleural effusion. The volume of thoracic effusion
was calculated by measuring areas of pleural effusion on a
tomogram and totaling the areas in each tomogram ob-
tained by slicing the thorax to a thickness of 1 cm (22). The
mean difference in interobserver agreement of right or left
pleural effusion by two different reviewers was 51.1 6 38 ml
(r 5 0.97; standard error of estimate 23.5 ml; p , 0.0001;
n 5 20 comparisons) and 42.6 6 42.7 ml (r 5 0.97; SEE
16.9 ml; p , 0.0001; n 5 20), respectively.
Study variables. Variables used to predict body fluid accumu-
lation included the following: presence of pulmonary crackles,
rales or wheezing, jugular venous distension or peripheral
edema on bedside physical examination, roentgenographic
evidence of pulmonary interstitial and alveolar edema or
pleural fluid and presence of pericardial effusion or pleural
effusion on ultrasonographic study for the heart and thorax.
Two observers independently evaluated each patient for the
presence or absence of these study variables. Consensus
agreements were reached when there was disagreement
between two observers.
Statistical analysis. Continuous variables were reported as
mean 6 SD and compared using Student t test. Categorical
variables were expressed as the percentage and compared
using the chi-square test or McNemar’s test, appropriately.
The agreement between two clinicians was assessed by
calculating the Kappa value; the strength of agreement is
“poor” when the value of kappa is less than zero, “slight”
from 0 to 0.20, “fair” from 0.21 to 0.40, “moderate” from
0.41 to 0.60, “substantial” from 0.61 to 0.80 and “almost
perfect” from 0.81 to 1.00 (23). Sensitivity was defined as 1
2 number of false negatives/number of true negatives;
specificity was defined as 1 2 number of false positives/
number of true negatives; and predictive accuracy was
defined as number of correct tests/number of patients tested
(24). A p value of less than 0.05 was considered to be
statistically significant.
RESULTS
Table 1 summarizes the demographic data and NYHA
functional classification. Table 2 lists various causes of
decompensated CHF in the 60 patients (mean age of
Figure 1. Representative example of the thoracic ultrasonograms
of a decompensated heart failure patient with bilateral pleural
effusion. Accumulation of pleural effusion (p) is noted adjacent to
the liver (L) in the right hemithorax (panel A) and adjacent to the
spleen (S) in the left hemithorax (panel B).
Table 1. Demographic Data and NYHA Functional
Classification (n 5 60)
Age (yr)
,65 10 (17%)
65–85 36 (59%)
.85 14 (24%)
Gender
Male 23 (38%)
Female 37 (62%)
NYHA functional
Class II 18 (30%)
Class III 18 (30%)
Class IV 24 (40%)
Blood chemistry
Hemoglobin (g/dl) 12.2 6 1.6
Range 9.8–16.7
Albumin (g/dl) 3.9 6 0.42
Range 2.7–4.8
Creatinine (mg/dl) 1.09 6 0.33
Range 0.5–1.9
Atrial natriuretic peptide (pg/ml) 172.8 6 22.0
Range 15–862
Brain natriuretic peptide (pg/ml) 691.5 6 638.0
Range 83–3,000
NYHA 5 New York Heart Association.
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76.0 6 12.9 years). Forty percent of the patients were in
NYHA class IV. Serum brain natriuretic peptide on admis-
sion was elevated in all, and atrial natriuretic peptide was
elevated in 49 patients (82%). Cardiac valve disease was the
most frequent etiology (43%) followed by arterial hyperten-
sion (20%) and chronic ischemic heart disease (15%). Atrial
fibrillation was present in 25 patients, the incidence being
high among the patients with valvular heart disease (14/26,
54%).
Detection of pleural effusion by thoracic ultrasonography
versus plain chest radiograph. Table 3 summarizes the
comparison of the presence of signs of pleural effusion
between plain chest radiograph and thoracic ultrasonogra-
phy related to changes in the volume of pleural effusion in
22 normal controls and 60 heart failure patients. On X-ray
thoracic CT, 52 of 60 heart failure patients (86.6%) and
none of the control subjects demonstrated pleural effusions.
In the 22 control subjects, one patient showed signs of
pleural effusion on the left thoracic ultrasonographic exam-
ination. In the 60 patients with decompensated CHF,
thoracic ultrasonography was highly accurate for identifying
the pleural effusion when compared with plain chest radio-
graph; even when there was a very small amount (#100 ml)
of pleural effusion, it was detected by thoracic ultrasonog-
raphy in as many as 80% (left hemithorax) to 87% (right
hemithorax) of the patients. In contrast, plain chest X-ray
examination detected only 13% of the cases in which there
was a very small amount of pleural effusion in the right
hemithorax. In total, thoracic ultrasonography identified
significantly more pleural effusion in each hemithorax than
did plain chest radiograph: 92% in the right hemithorax and
93% in the left hemithorax and only 48% (p , 0.001) and
26% (p , 0.001) in the plain chest radiograph, respectively.
Incidence of clinical signs of body fluid accumulation.
Table 4 shows the frequency of clinical signs of body fluid
Table 2. Etiology of CHF
Etiology
Number of
Patients
Cardiac valve disease
Mitral regurgitation 9
Aortic regurgitation 5
Aortic stenosis 1
Tricuspid regurgitation 2
Combined regurgitant valve disease 7
Mitral stenosis 2
Arterial hypertension 12
Chronic ischemic heart disease 9
Hypertrophic cardiomyopathy 4
Idiopathic dilated cardiomyopathy 1
Rhythm disturbance
Atrial fibrillation 4
Atrioventricular block 1
Combined* 3
Total 60
*Combined: more than one etiology primarily involved.
Table 3. Comparison of the Presence of Signs of Pleural Effusion Between Plain Chest X-ray
and Thoracic Ultrasonogram in Normal Controls and Patients With Decompensated CHF
Pleural Effusion by CT
Right Hemithorax Left Hemithorax
n X-ray Echo n X-ray Echo
Normal controls (n 5 22)
Absent 22 0 0 22 0 1 (5)
Patient group (n 5 60)
Absent 10 0 1 (10) 14 0 2 (14)
Present (ml)
Very small (#100) 15 2 (13) 13 (87) 15 0 12 (80)
Small (#400) 20 9 (45) 18 (90) 23 6 (26) 23 (100)
Moderate (#700) 8 6 (75) 8 (100) 6 4 (67) 6 (100)
Large 7 7 (100) 7 (100) 2 2 (100) 2 (100)
Total 50 24 (48) 46 (92) 46 12 (26) 43 (93)
Numbers in parentheses are percentages.
Echo 5 thoracic ultrasonography.
Table 4. The Frequency of the Detection of Body Fluid
Accumulation in 60 Patients With Decompensated CHF by
Two Clinicians
A
(%)
B
(%)
Combined
(%)
Physical findings
Rales or wheezing 35 (58) 32 (53) 33.5 (56)
Jugular venous distension 25 (42) 20 (33) 22.5 (38)
Peripheral edema 20 (33) 20 (33) 20 (33)
Any 35 (58) 39 (65) 37 (62)
Chest roentgenogram
Pulmonary edema 28 (47) 26 (43) 27 (45)
Pleural effusion 23 (38) 26 (43) 24.5 (41)
Any 34 (57) 39 (65) 36.5 (61)
Ultrasonography
Pericardial effusion 13 (22) 12 (20) 12.5 (21)
Pleural effusion 55 (92) 54 (90) 54.5 (91)
Any 55 (92) 54 (90) 54.5 (91)
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accumulation in 60 patients with decompensated CHF by
two clinicians. Reported incidence was excellently high in
the variable of the pleural effusion detected by thoracic
ultrasonography (90% to 92%). The incidence of rales or
wheezing was modest (53% to 58%) but that of other
physical signs of jugular venous distension (33% to 42%)
and peripheral edema (33%) was low. On chest radiograph,
the frequency of the presence of pulmonary edema (43% to
47%) or pleural effusion (38% to 43%) was low, but the
presence of two or more variables moderately predicted
body fluid accumulation (57% to 65%).
Interobserver agreement on the presence or absence of
clinical signs of body fluid accumulation. Table 5 sum-
marizes the interobserver agreement on the reported clinical
tests for identifying body fluid accumulation in patients with
decompensated CHF, which varied widely and ranged from
72% to 95%. Among study variables, there was substantial
to almost perfect agreement between the two observers on
the results of the thoracic ultrasonography (95% overall
agreement, kappa 5 0.70), echocardiography (95% overall
agreement, kappa 5 0.848) and on the presence or absence
of pleural effusion on plain chest radiograph (88% concor-
dance, kappa 5 0.759). There was also substantial agree-
ment between the two observers for pulmonary rales (85%
overall agreement, kappa 5 0.697). There was only 72%
agreement on interpretations for the presence or absence of
jugular venous distension (kappa 5 0.40), 81% agreement
on recognizing peripheral edema (kappa 5 0.609) and 73%
concordance in identifying pulmonary interstitial edema on
chest radiograph (kappa 5 0.462).
Comparative diagnostic value of study variables. Table 6
shows the comparative data of sensitivity, specificity and
predictive accuracy of study variables for the diagnosis of
body fluid accumulation. The best clinical variable for
identifying patients with decompensated CHF was the
detection of pleural fluid by thoracic ultrasonography (91%
predictive accuracy). There was only 41% to 65% predictive
accuracy of the other clinical variables examined.
Follow-up data. After a follow-up period of 16.2 6 4.5
days (range 10–30 days), 54 patients with decompensated
CHF on admission showed definite clinical improvement
after effective diuresis, as documented by clinical examina-
tions in addition to a net negative fluid balance or significant
weight loss and serum assay of natriuretic peptides; the
serum level of atrial and brain natriuretic peptides decreased
to 54.0 6 38.9 pg/ml and 204.6 6 215.5 pg/ml, respec-
tively. Both were significantly different from admission
Table 5. Observer Disagreement on Clinical Tests for Identifying Body Fluid Accumulation in
60 Patients With Decompensated CHF
Observations of
Observer A
Number of
Observations by
Observer B
Agreement (%) Kappa CoefficientsPresent Absent
Physical findings
Rales or wheezing
Present 29 3
Absent 6 22 85 0.697
Jugular venous
distension
Present 14 6
Absent 11 29 72 0.400
Peripheral edema
Present 17 5
Absent 6 32 81 0.609
Chest roentgenogram
Pulmonary edema
Present 19 7
Absent 9 25 73 0.462
Pleural effusion
Present 21 5
Absent 2 32 88 0.759
Ultrasonography
Pericardial effusion
Present 11 1
Absent 2 46 95 0.848
Pleural effusion
Present 53 1
Absent 2 4 95 0.700
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levels (p , 0.0001 in each). In the remaining six patients
with decompensated CHF, the clinical course deteriorated
during the follow-up period; four patients died from ad-
vanced heart failure, one patient refractory to heart failure
treatment, and another case was complicated by a serious
cerebrovascular accident.
DISCUSSION
Because heart failure is a clinical syndrome that is caused by
abnormal cardiac function, the major goals in the evaluation
of patients with heart failure are:
1) to identify the nature and severity of the cardiac
abnormality,
2) to characterize the nature and severity of the patient’s
functional limitation, and
3) to assess the presence and severity of fluid retention (5).
With regard to assessment of the presence and severity of
fluid retention, results of this study indicate that thoracic
ultrasonography is a simple, sensitive and accurate method
for evaluation of patients with decompensated CHF. When
compared with traditional physical and chest radiographic
examinations, this method proves to be very useful for
identifying the signs of body fluid accumulation.
Body fluid retention in CHF. Chronic heart failure re-
sulting from diminished cardiac function is invariably
caused by an abnormality of the muscle, rhythm, valves or
pericardium. The syndrome of CHF is the response of the
body to the heart’s inability to maintain an adequate blood
supply at a rate commensurate with the requirements of the
metabolizing tissues. The primary problem in CHF is
cardiac, but the clinical syndrome is characterized by sec-
ondary multisystem dysfunction, which ultimately leads to a
terminal state of multiorgan failure (25). The reduction in
cardiac output that occurs in the failing heart activates the
sympathetic nervous system (26,27), resulting in an in-
creased heart rate and vasoconstriction. A decrease in renal
perfusion results in activation of the renin-angiotensin-
aldosterone system, leading to production of the powerful
vasoconstrictor angiotensin II and, ultimately, sodium re-
tention through the actions of aldosterone (28,29). Water
retention is also augmented by vasopressin production from
the posterior pituitary (30). Other potent vasoconstrictors,
such as endothelin, contribute to an increase in peripheral
vascular resistance (31,32). These changes might not be
sufficiently counteracted by the cardiac endocrine system,
which produces natriuretic and vasodilating atrial and brain
natriuretic peptides (9,10,33,34). As a result, this sequence
of the spiraling course of heart failure induces more and
more retention of sodium and water and is ultimately
punctuated by acute exacerbations (so-called decompen-
sated CHF) that require hospital admission.
Symptoms of heart failure. The classical symptoms of
heart failure are dyspnea, ankle edema and fatigue. Dyspnea
on exertion is common in the general population, particu-
larly in patients with respiratory disease or in the obese, and,
therefore, it cannot be used as the selection criterion for the
diagnosis of heart failure (25). Orthopnea and paroxysmal
nocturnal dyspnea are less common in the general popula-
tion than dyspnea alone, but less sensitive, for the diagnosis
of heart failure (2,25,35–38). Additionally, there are many
asymptomatic or minimally symptomatic patients who are
existing even in the uncontrolled stage of CHF, particularly
among aged patients in whom the prevalence increases
sharply, affecting perhaps as many as 5% to 10% of individ-
uals over the age of 65 (39,40). In this study, the incidence
of mild subjective symptoms of heart failure (NYHA class
II) tended to be higher in patients $75 years (15 of 40
patients, 38%) than in younger patients (3 of 20, 15%; p ,
0.1). The most probable reasons for the lack of subjective
heart failure symptoms in the aged are their low level of
daily activity or high rate of complicating cerebrovascular
disease, which should obscure complaint of the dyspneic
sensation.
Classical clinical signs of body fluid accumulation in
CHF. An accurate objective measurement of the presence
of body fluid retention is necessary in order to evaluate
patients with decompensated CHF. The difficulty in clini-
Table 6. Comparative Diagnostic Value of Traditional Clinical Signs and Ultrasonographic Test
for Identifying Body Fluid Accumulation in Decompensated CHF
Sensitivity
(%)
Specificity
(%)
Predictive Accuracy
(%)
Physical findings
Rales or wheezing 33/60 (55) 20/22 (91) 53/82 (65)
Jugular venous distension 24/60 (40) 19/22 (86) 43/82 (52)
Peripheral edema 22/60 (37) 21/22 (95) 43/82 (52)
Chest roentgenogram
Pulmonary edema 27/60 (45) 20/22 (91) 47/82 (57)
Pleural effusion 26/60 (43) 22/22 (100) 48/82 (59)
Ultrasonography
Pericardial effusion 12/60 (20) 22/22 (100) 34/82 (41)
Pleural effusion 54/60 (90) 21/22 (95) 75/82 (91)
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cally defining such patients, however, stems from the fact
that no simpler or more objective sign of body fluid
accumulation is currently available because there is no clear
cut-off sign of fluid accumulation that can be used reliably to
identify subjects with decompensated CHF. Previous expe-
riences indicate that some patients with decompensated
CHF have no classical clinical or radiographic signs of
congestion, despite markedly elevated pulmonary filling
pressures and decreased cardiac output (12,41).
Body fluid retention in decompensated CHF is reflected
in physical signs of congestion, such as ankle edema, jugular
venous distension and pulmonary crackles. Plain chest
radiograph is also a traditional standard method of choice to
obtain objective evidence of body fluid accumulation. At
least seven studies (2,12,35–37,42,43) have examined the
sensitivity, specificity and predictive value of physical signs
for diagnosis of heart failure (25). These studies suggest that
none of the signs of fluid retention (i.e., peripheral edema,
jugular venous distension and pulmonary rales) is particu-
larly sensitive, though specificity varied among studies (25).
Additionally, some studies have shown that there is dis-
agreement among several clinicians regarding recognition of
classical physical signs of heart failure (44,45). The results of
this study are consistent with these previous observations;
the incidence of classical physical signs for identifying body
fluid accumulation and the agreement between two observ-
ers on these signs, except for pulmonary rales, were only
modest.
Radiography is still a standard method for evaluating
heart failure patients. Two important specific markers for
fluid accumulation on plain chest radiograph are pleural
effusion and interstitial edema (hilar haziness, peribronchial
cuffing, Kerley B lines) or alveolar pulmonary edema.
Radiographic identification of pleural effusion (15,17), how-
ever, is reported to be insensitive and detects only moderate
to large accumulation of pleural fluid. Indeed, this study
demonstrated that detection of the fluid in either hemitho-
rax using plain X-ray occurred in only 38% to 43% of
patients and was confirmed by using X-ray thoracic CT,
though concordance by two observers in identifying this
sign was substantial. The incidence of roentgenographic
signs of pulmonary congestion was also not high, and the
interobserver agreement of this sign was only modest, which
is consistent with previous observations (12,46). Previous
reports suggested that chronically high left-sided heart
pressures permit compensatory mechanisms to correct the
fluid shift that has occurred, which can mask clinical and
radiographic evidence of the underlying hemodynamic de-
rangements. Increased lymphatic drainage will clear flooded
alveoli, and radiographic evidence of edema might be absent
(12,47,48).
Role of ultrasonography for detection of body fluid
accumulation. The findings of the X-ray thoracic CT in
this study indicated that as many as 90% of decompensated
CHF patients have pleural effusion, suggesting that CT
scan might be very useful for confirming pleural effusion in
the uncontrolled stage of CHF. The most frequently en-
countered problems with CT scans are, however, difficulty
in transporting critically ill patients and compelling the
orthopneic patient to assume a supine position during the
examination, which makes X-ray thoracic CT scans incon-
venient or impractical (19). This study clearly demonstrated
that thoracic ultrasonography efficiently supplemented the
role of CT scan for the diagnosis of pleural effusion in
decompensated CHF. Most importantly, the best clinical
sign for identifying patients with decompensated CHF
among the study variables was the detection of pleural fluid
by thoracic ultrasonography. In our experience, evaluation
of CHF patients using this method often revealed unex-
pected body fluid accumulation and changed patient man-
agement. The use of ultrasonography to detect decreased
pleural effusion could become one of the most useful
markers for confirming the therapeutic effectiveness of
decompensated CHF. Of course, it should be kept in mind
that the signs of body fluid accumulation, including thoracic
ultrasonography, have a limited value for revealing latent
myocardial failure or predicting the prognosis of CHF
patients, because these markers are evident only with acute
exacerbation of CHF. The measurement of one or more
natriuretic peptides (9,10,33,34) will be more useful for this
purpose.
Echocardiography combined with Doppler study is rap-
idly establishing itself as the primary investigation in pa-
tients with suspected heart failure (49–52). Thoracic ultra-
sonography, however, is not currently used in the routine
assessment of heart failure patients. This technique has
several advantages: 1) high predictive accuracy in detecting
body fluid accumulation, 2) ease of performance at bedside,
3) flexibility and short examination time compared with
X-ray thoracic CT scan, and 4) lower cost. These advan-
tages make thoracic ultrasonography a useful diagnostic tool
with great potential for assisting decision making and
management of patients with decompensated CHF.
Several disadvantages should also be pointed out:
1) technical difficulty in obtaining a high quality of image
in obese patients,
2) restricted field of view and
3) operator dependence.
Though recent guidelines for the evaluation and manage-
ment of heart failure reported from the European Society of
Cardiology (51) or from the American College of Cardiol-
ogy/American Heart Association (52) do not include tho-
racic ultrasonography as a diagnostic tool for the evaluation
of heart failure patients, this technique should be performed
at an early stage in the management of any patient with a
suspected diagnosis of CHF in order to obtain objective
evidence of fluid accumulation in the pleural cavity.
Study limitations. There are important limitations to this
study:
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1) The major limitation of this study is the small number
of patients and the lack of an additional control group
of outpatients with stable CHF.
2) It is necessary to have an objective measure of whether
body fluid accumulation is truly present in order to
establish diagnostic accuracy and interobserver agree-
ment of any given symptom or sign. There is, however,
no gold standard test for the objective measure of body
fluid accumulation in a clinical setting.
3) A valvular etiology due to degenerative valve disease in
the aged was most frequent in this study, which is
different from recent literature that report coronary
artery disease predominance (53). This probably reflects
the peculiar fact that patients with ischemic heart
disease were preferentially referred to other hospital
coronary care units because our hospital does not have
a coronary care unit. Any impact of the inclusion of
many heart failure patients due to chronic ischemic
heart disease on the present form of study remains to be
determined.
4) Previous studies report the clinical usefulness of the
abdominojugular test (12) in assessing CHF patients.
This variable was not evaluated in this study.
5) The findings of this study on body fluid retention in
decompensated “chronic” heart failure cannot be ex-
trapolated to those observed in “acute” heart failure (8),
because compensatory mechanisms to correct the body
fluid accumulation would differ between these two
clinical syndromes (12,41,45,54).
Conclusions. Diagnosis of decompensated CHF in gen-
eral practice is likely to remain haphazard and will continue
to require objective substantiation. Results of this study
indicated that thoracic ultrasonography is a simple, sensitive
and accurate method for evaluation of the body fluid
accumulation in patients with decompensated CHF. This
technique can be used to assist in making the diagnosis of
decompensated CHF and in the investigation of CHF
patients during the follow-up period, if other causes of
pleural effusion have been clinically ruled out.
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